BC
Bradley Canino Guggenheim Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
23
Avg Return
Past Year
Past Year
12%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
83.3%
Neutral
16.7%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Initiated
| $90 |
108%
upside
| 1 | +14% |
0
%
| 8 Oct ‘25 4 days ago |
|
|
|
Buy
Initiated
| $20 |
89%
upside
| 1 | +1.2% |
0
%
| 8 Oct ‘25 4 days ago |
|
|
|
Buy
Initiated
| $110 |
139%
upside
| 1 | -11% |
0
%
| 22 Sep ‘25 20 days ago |
|
|
|
Buy
Reinstated
| $44 |
174%
upside
| 3 | -5.4% |
0
%
| 10 Sep ‘25 1 month ago |
|
|
|
Buy
Reinstated
| $45 |
70%
upside
| 3 | -9.3% |
0
%
| 10 Sep ‘25 1 month ago |
|
|
|
Buy
Assumed
| $18 |
32%
upside
| 1 | +29% |
0
%
| 4 Sep ‘25 1 month ago |
|
|
|
Buy
Assumed
| $15 |
131%
upside
| 2 | +34% |
0
%
| 4 Sep ‘25 1 month ago |
|
|
|
Buy
Assumed
| $122 |
38%
upside
| 1 | +11% |
0
%
| 4 Sep ‘25 1 month ago |
|
|
|
Buy
Initiated
| $8 |
256%
upside
| 1 | -12% |
0
%
| 4 Sep ‘25 1 month ago |
|
|
|
Neutral
Initiated
| – | – | 2 | – |
–
| 4 Sep ‘25 1 month ago |
|
|
|
Buy
Initiated
| $8 |
96%
upside
| 2 | +47% |
0
%
| 4 Sep ‘25 1 month ago |
|
|
|
Buy
Initiated
| $40 |
87%
upside
| 1 | -9.2% |
0
%
| 4 Sep ‘25 1 month ago |
|
|
|
Buy
Initiated
| $5 |
35%
upside
| 1 | +152% |
0
%
| 4 Sep ‘25 1 month ago |
|
|
|
Hold
Maintained
| $1.50 |
9%
downside
| 1 | – |
–
| 7 Mar ‘25 7 months ago |
|
|
|
Buy
Maintained
| $19 |
157%
upside
| 1 | -14% |
0
%
| 28 Feb ‘25 7 months ago |
|
|
|
Buy
Maintained
| $51 |
439%
upside
| 1 | -46% |
0
%
| 12 Feb ‘25 8 months ago |
|